Company intelligence / Profile preview

ATMA CENA Healthcare Solutions

Calgary, Alberta, Canada

Ownership: Private
Development stage: Other

Overview

ATMA CENA Healthcare Solutions operates a network of clinics across Canada providing evidence-based psychedelic-assisted therapy, including ketamine therapy (commercial), and MDMA/psilocybin where regulatory approval allows. Alberta Blue Cross has begun insurance coverage for select therapies, making ATMA CENA one of the first Canadian networks positioned for broad reimbursement and patient access.

Therapeutic areas: OtherNeurologyPsychiatry
Modalities: Small molecule (ketamine, MDMA)Natural product (psilocybin)Device (repetitive transcranial magnetic stimulation, rTMS)
Industry: Non-Academic Healthcare

Partnerships

Alberta Blue Cross (insurance coverage for psychedelic therapy)Canada-wide network clinics

Beyond the preview

Go deeper on ATMA CENA Healthcare Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATMA CENA Healthcare Solutions.

Explore the full profile